BLK stock · EKSO stock

BLK vs EKSO · P/E 27, rev $24.22B vs $42.0M cap

BlackRock Inc (BLK) versus Ekso Bionics Holdings Inc (EKSO) — a side-by-side from cached financials, not a winner call.

BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.

Ekso Bionics Holdings Inc (EKSO) is a medical instruments & supplies company listed on NASDAQ.

Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.

EKSO does not have a complete income-statement cache yet.

BLK currently screens at market cap $172.19B and trailing P/E 26.6. EKSO currently screens at market cap $42.0M.

Not investment advice. Open the BLK and EKSO stock pages for the full models.

Not investment advice.

Popular Stock Comparisons